Overview

Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

Status:
Completed
Trial end date:
2021-08-18
Target enrollment:
Participant gender:
Summary
The purpose of study is to assess the efficacy of add-on estrogen pretreatment in GnRH antagonist protocol on oocyte retrieval as compared with GnRH antagonist protocol for patients with poor ovarian response Add-on estrogen pretreatment protocol is superior to none pretreatment GnRH antagonist protocol for the number of oocytes retrieval
Phase:
N/A
Details
Lead Sponsor:
Reproductive & Genetic Hospital of CITIC-Xiangya
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Follicle Stimulating Hormone
Ganirelix
Polyestradiol phosphate